Corrigendum to “miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells” [Biomed. Pharmacother. 84 (2016) 947–953]
Jing Wang,
Bing Wang,
Ling-Qiang Chen,
Jin Yang,
Zhi-Qiang Gong,
Xue-Ling Zhao,
Chun-Qiang Zhang,
Kai-Li Du
Affiliations
Jing Wang
Department of Rheumatology, The First People’s Hospital of Yunnan Province, Kunming, 650032, Yunnan, China
Bing Wang
Department of Orthopedics, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China
Ling-Qiang Chen
Department of Orthopedics, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China; Corresponding author at: Department of Orthopedics, The First Affiliated Hospital of Kunming Medical University, 295 Xichang Road, Kunming, 650032, Yunnan Province, China.
Jin Yang
Department of Orthopedics, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China
Zhi-Qiang Gong
Department of Orthopedics, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China
Xue-Ling Zhao
Department of Orthopedics, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China
Chun-Qiang Zhang
Department of Orthopedics, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China
Kai-Li Du
Department of Orthopedics, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China
